Innov Clin Neurosci. 2024;21(7–9):8–9. Dear Editor: In the treatment of chronic pain of unknown cause, contradictions can arise; a drug for the treatment of a disease might be a cause
by Jonathan R. Scarff, MD, and Steven Lippmann, MD Dr. Scarff is Staff Psychiatrist, Veterans Affairs Medical Center in Lexington, Kentucky. Dr. Lippmann is Professor Emeritus, University of Louisville School
by Richard G. Cockerill; Bridget K. Biggs, PhD; Tyler S. Oesterle, MD; and Paul E. Croarkin, DO Mr. Cockerill is a student at Mayo Medical School, College of Medicine, Mayo
by Lawrence D. Ginsberg MD; Alondra Y. Oubre PhD; and Yahya A. Daoud, MS Dr. Ginsberg is from Red Oak Psychiatry Associates, PA, Houston, Texas; Dr. Oubre is from Writing
by Susan Lenderts, BA, and Amir H. Kalali, MD Ms. Lenderts is Associate Director, Global Commercial Partnering, Quintiles Commercial, Durham, North Carolina; Dr. Kalali is Vice President, Global Therapeutic Group
by Randy A. Sansone, MD, and Lori A. Sansone, MD Dr. R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of
by Elisa Cascade; Amir H. Kalali, MD; and Sidney H. Kennedy, MD, FRCPC Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic
by Randy A. Sansone, MD, and Lori A. Sansone, MD Dr. R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of
by Elisa Cascade; Amir H. Kalali, MD; and Uriel Halbreich, MD Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader
